SITE008-0072

SITE008 (KOR) › SITE008-0072

SITE008-0072

A Phase III, Randomized, Double-Blind Study of Torivumab Plus Chemotherapy Versus Placebo Plus Chemotherapy in Previously Untreated Advanced Non-Small Cell Lung Cancer · Phase III
SITE008 (KOR) · Dr. Kim
consented 2025-11-29

enrolled

AEs

4

Serious

0

Dropout signal

–

Adverse events

4

Grade 1 Diarrhoea — outcome: RECOVERED/RESOLVED; onset 2022-11-30 (study day 182); relationship: RELATED

mild assessed

Grade 2 Thrombocytopenia — outcome: RECOVERED/RESOLVED; onset 2022-10-16 (study day 137); relationship: NOT RELATED

moderate assessed

Grade 2 Vomiting — outcome: RECOVERED/RESOLVED; onset 2022-09-19 (study day 110); relationship: not assessed

moderate assessed

Grade 3 Constipation — outcome: RECOVERED/RESOLVED; onset 2022-07-24 (study day 53); relationship: not assessed

severe assessed

Data queries

0

No data queries. Open queries would appear here for this patient.